Article Details

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine

Retrieved on: 2024-11-20 17:56:48

Tags for this article:

Click the tags to see associated articles and topics

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine. View article details on hiswai:

Excerpt

The initial antigenic shift to Omicron BA.1, followed by the dominance of Omicron BA.4/5, prompted updates to COVID-19 vaccines to better match ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up